MP15-15 WHO ARE THE PATIENTS WHO BENEFIT THE MOST FROM EXTENDED PELVIC LYMPH NODE DISSECTION IN LOCALIZED PROSTATE CANCER? IDENTIFICATION OF THE OPTIMAL CANDIDATES TO BE INCLUDED IN A RANDOMIZED CONTROLLED TRIAL
Abstract
You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy I (MP15)1 Sep 2021MP15-15 WHO ARE THE PATIENTS WHO BENEFIT THE MOST FROM EXTENDED PELVIC LYMPH NODE DISSECTION IN LOCALIZED PROSTATE CANCER? IDENTIFICATION OF THE OPTIMAL CANDIDATES TO BE INCLUDED IN A RANDOMIZED CONTROLLED TRIAL Giorgio Gandaglia, Giuseppe Rosiello, Simone Scuderi, Nicola Fossati, Armando Stabile, Andrea Necchi, Vito Cucchiara, Riccardo Leni, Donato...
Paper Details
Title
MP15-15 WHO ARE THE PATIENTS WHO BENEFIT THE MOST FROM EXTENDED PELVIC LYMPH NODE DISSECTION IN LOCALIZED PROSTATE CANCER? IDENTIFICATION OF THE OPTIMAL CANDIDATES TO BE INCLUDED IN A RANDOMIZED CONTROLLED TRIAL
Published Date
Sep 1, 2021
Journal
Volume
206
Issue
Supplement 3
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History